Effects of Anthocyans on Cardiovascular and Sympathetic Function

Anthocyans modify cardiovascular and sympathetic function

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

35 year–50 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Cardiovascular and Renal Research Center, Ulleval University Hospital

Oslo, 0407, Norway

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Ages 35 to 50 years old
Males
Hypertension

Treatment and study plan

Anthocyans

Dietary Supplement

Anthocyans

Placebo

Other

Primary outcomes

Systolic bloodpressure and heartrate

Sponsors and collaborators

Lead sponsor

Ullevaal University Hospital

Other

Collaborators

MedPalett

Registry information

Important dates

Study start: 2008
Primary completion: 2009
Study completion: 2009
First posted: Mar 13, 2008
Registry last updated: Jul 6, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed